Breaking the AI Gender Gap

This research demonstrates a selective cost reduction and error control mechanism-SCoRE-that optimizes predictions in both drug discovery and clinical applications; in drug discovery, SCoRE minimizes average cost [latex]L\_{n+1}\operatorname{\mathds{1}}\{Y\_{n+1}\leq c\}[/latex] among selected compounds while maintaining activity below a threshold of [latex]\alpha=1[/latex], and in clinical prediction, it identifies health outcome predictions with minimal error [latex]f(X\_{n+1})\approx Y\_{n+1}[/latex] and controls total squared error during deployment, as validated through simulations on a semi-synthetic dataset.

New research highlights how unconscious biases and limited representation hinder women’s success in artificial intelligence and proposes solutions for a more equitable future.